What AUC Measures and Why It Matters

Plot plasma concentration against time after a dose and you get a curve that rises to a peak and then decays. The area beneath that curve is total systemic exposure, expressed in units such as milligram hours per litre. It answers a question no single measurement can: not how high the concentration reached, nor how low it fell before the next dose, but how much drug the body was exposed to overall and for how long.

That distinction has practical weight. Two dosing regimens can produce identical trough concentrations while delivering substantially different total exposure, and for many drugs it is the exposure that drives both bacterial killing and organ toxicity. AUC is therefore the pharmacodynamic index of choice for glycopeptides such as vancomycin, for several oncology agents where exposure predicts myelo- suppression, and for immunosuppressants like mycophenolate where a narrow therapeutic window makes precise exposure targeting essential.

The Trapezoidal Rule, Linear Up and Log Down

Since concentration is sampled at discrete times rather than measured continuously, AUC is estimated by summing the areas of the segments between consecutive points. The simplest approach treats each segment as a trapezoid with straight sides. That works well while concentrations are rising, but it systematically overestimates during elimination, because first-order decay is exponential and a straight chord always sits above the true curve.

The linear-up, log-down method used here fixes that. While concentrations rise it applies the linear trapezoid; while they fall it integrates the exponential form, computing the segment as the concentration difference multiplied by the time interval and divided by the natural logarithm of the concentration ratio. The correction is modest when samples are closely spaced and becomes substantial when intervals are long or the decay is steep, which is exactly the situation in sparse clinical sampling.

Extrapolating to Infinity and Judging the Fit

AUC₀→t stops at your last sample, but drug remains in the body after that point. Extending to AUC₀→∞ adds a tail equal to the final concentration divided by the terminal elimination rate constant, which this calculator derives by log-linear regression over the last points. The same constant yields the half-life through the natural logarithm of two, and combines with clearance to give the volume of distribution.

Two diagnostics decide whether that extrapolation can be trusted. The extrapolated percentage should stay below twenty percent of the total; above that, sampling ended too early and the estimate rests more on the model than on data. The coefficient of determination for the terminal regression should exceed 0.95, indicating the points genuinely lie in the terminal phase rather than still reflecting distribution. Both figures are reported here so a weak estimate is visible rather than hidden inside a confident-looking number.

AUC-Guided Vancomycin Dosing in Practice

The 2020 consensus guideline published jointly by ASHP, IDSA, PIDS and SIDP moved vancomycin monitoring for serious MRSA infection away from trough-only targeting toward an AUC₂₄ to MIC ratio of 400 to 600. The evidence behind that change was consistent: trough targets of 15 to 20 mg/L delivered exposure beyond what efficacy required while roughly doubling rates of acute kidney injury, whereas AUC-guided regimens achieved comparable clinical outcomes at lower total exposure.

Implementing it requires either two well-timed levels within a dosing interval or Bayesian estimation against a population model. Timing dominates accuracy: the peak must be drawn after distribution is complete, generally one to two hours after the infusion ends, and actual draw times must be recorded rather than assumed from the schedule. Clearance falls with declining renal function, so the same dose produces higher exposure as creatinine clearance drops, and concurrent nephrotoxins such as piperacillin-tazobactam compound the risk. This calculator is an educational aid for understanding and checking that arithmetic; clinical decisions belong with validated monitoring software and the judgement of the treating team.